Atlas Trials

Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers

Clinical trial NCT03193931 · TERMINATED

Trial details

NCT number
NCT03193931
Sponsor
AIO-Studien-gGmbH
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of Head and Neck
Start date
2018-02-02
Primary completion
2021-11-24
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.